The three commonly used biomarkers Troponin I, CK-MB andMyoglobin show delayed elevations following myocardial injury so their effectiveness diminishes in early ACS detection [1].The research findings showed heart-type fatty acid-binding protein (H-FABP), copeptin and ischemia modified albumin (IMA) exceededtraditional biomarkers when detecting acute coronary syndrome diagnosis at an early stage. This evidence concerns the gene FABP3 and acute coronary syndrome.